QT
AMLX icon

Quantbot Technologies’s Amylyx Pharmaceuticals AMLX Stock Holding History

Quantbot Technologies’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,653
Closed -$226K – 1679
2025
Q3 		$226K Buy
+16,653
New +$157K 0.01% 1257
2023
Q2 		– Sell
-4,859
Closed -$143K – 1543
2023
Q1 		$143K Buy
+4,859
New +$169K 0.01% 995
2022
Q2 		– Sell
-2,200
Closed -$28K – 1674
2022
Q1 		$28K Buy
+2,200
New +$49.7K ﹤0.01% 1308

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Quantbot Technologies's AMLX Position: Q4 2025 in Review

Quantbot Technologies sold out of Amylyx Pharmaceuticals (AMLX) in Q4 2025, closing a stake of 16,653 shares — an estimated $226K sold.

Quantbot Technologies first reported a position in AMLX in Q1 2022 and held it in 3 quarters. The position peaked at $226K in Q3 2025. 179 funds tracked by Wall St. Rank hold AMLX as of Q4 2025.

  • Quantbot Technologies reported no remaining Amylyx Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Quantbot Technologies sold 16,653 Amylyx Pharmaceuticals shares in Q4 2025, an estimated $226K.
  • Quantbot Technologies first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Quantbot Technologies's Amylyx Pharmaceuticals position peaked at $226K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q4 2025.

Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.